https://www.thebodypro.com/category/hiv-treatments-in-development/tag/ias-international-aids-society-conference
HIV Treatments in Development

IAS (International AIDS Society) Conference

The Latest

Full panel for HIV Treatment Research: New Drugs and More Efficient Regimens press conference

What's New in HIV Treatment: A Report on Updates from IAS 2019

Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

MK-8591: Further Compelling Early Results for Both Treatment and Prevention Img

MK-8591: Further Compelling Early Results for Both Treatment and Prevention

Two interesting early studies on the investigational NRTI MK-8591 (EFdA) were presented at IAS 2017. This compound is notable for a very high potency, a long-half life and the potential for use both as HIV treatment and for HIV prevention.

HIV Pipeline Drugs: IAS 2017 Update Img

HIV Pipeline Drugs: IAS 2017 Update

A review of HIV drugs in development that summarizes the most exciting new research over the previous year.

Phase 3 Results With Bictegravir -- A New Integrase Inhibitor Combined With FTC/TAF Img

Phase 3 Results With Bictegravir -- A New Integrase Inhibitor Combined With FTC/TAF

Two studies presented at IAS 2017 showed bictegravir to be very similar in efficacy to dolutegravir with slight differences in the formulations linked to the background NRTIs in the fixed-dose combinations.

HIV Remission News From IAS 2017 Img

HIV Remission News From IAS 2017

Treatment Action Group's Richard Jefferys provides a comprehensive overview of HIV remission presentations at the 9th International AIDS Society Conference on HIV Science.

Promo Image

HIV Antiretroviral Therapy: Past, Present and Future

In the last two decades, antiretroviral therapy has dramatically improved the health of people living with HIV. Let’s take a brief look at the past and present before we look forward to HIV treatment in 2020.

Joel Gallant on Tenofovir Alafenamide (TAF) and Aging HIV Providers (Video) Img

Joel Gallant on Tenofovir Alafenamide (TAF) and Aging HIV Providers (Video)

In this interview, Joel E. Gallant, M.D., M.P.H., discusses new HIV drugs in the pipeline and the lack of young people becoming HIV care specialists.

Asier Sáez-Cirión on Functional HIV Cure in French Teenager (Video) Img

Asier Sáez-Cirión on Functional HIV Cure in French Teenager (Video)

Asier Sáez-Cirión, Ph.D., of the Institut Pasteur in Paris, sits down with IFARA to talk about his case study of a French teenager who has achieved HIV remission for 12 years.

Sharon Lewin on Finding a Cure for HIV (Video) Img

Sharon Lewin on Finding a Cure for HIV (Video)

A long-term aspirational goal is the elimination of HIV. In 1996, highly active antiretroviral therapy was thought to constitute a cure. Then latency was discovered to be a cure barrier. Today, achieving long-term remission of the virus is considered...